Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2003
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292671A1 Method for obtaining characterised muscle-derived cell populations and uses
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292616A2 Nucleic acids encoding a regulator of g protein signaling, rgs18, and uses thereof
03/19/2003EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties
03/19/2003EP1292605A2 Antisense modulation of inhibitor of dna binding-1 expression
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292596A1 1,3,8-triaza-spiro[4,5]decan-4-one derivatives as neurokinin receptor antagonists
03/19/2003EP1292592A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1292577A2 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
03/19/2003EP1292574A1 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1292363A2 Carboxyalkylether-acat inhibitor combinations
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292317A1 Hypotensive and hypertensive properties of renomedullar extracts
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1292303A1 A stable pharmaceutical formulation comprising torsemide modification ii
03/19/2003EP1292302A2 Method of treating cardiovascular disease using rapamycin
03/19/2003EP1292301A1 Treatment and prevention of cardiac insulin resistance associated conditions
03/19/2003EP1292292A1 Method for treating congestive heart failure
03/19/2003EP1292288A2 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1137671B1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1060162B1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/19/2003EP0963370B1 Integrin antagonists
03/19/2003EP0888309B1 Imidazole derivatives having affinity for alpha2 receptors activity
03/19/2003EP0831798B1 Use of selegiline to treat hearing loss in mammals
03/19/2003EP0736093B1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB-2 PLAYS A ROLL
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/19/2003CN1404471A Substituted piperazine compounds
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404467A Aminosulfonylbiphenyl derivatives
03/19/2003CN1404391A Treating allergic and inflammatory conditions
03/19/2003CN1403470A Astragalus saponin A with the function of resisting myocardial fibrillation
03/19/2003CN1403456A Chiral isoquinoline compound with cardiac vascular activity and its synthesis process
03/19/2003CN1403452A Astragalus calycosin and its glycoside with the function of resisting myocardial ischemia
03/19/2003CN1403451A Balsamiferous biumea general flavone extractive and its extraction process and medicinal application
03/19/2003CN1403164A Special glue for treating hernia (the application of alpha-cyanacrylate in preparation of medical adhesive for treating hernia)
03/19/2003CN1403156A Application of human urokininogenase in preparing medicine for preventing and treating cerebral infraction
03/19/2003CN1403150A Medical health oral liquid and its prepn
03/19/2003CN1403149A Medicines composition for treating chronic heart failure and its prepn
03/19/2003CN1403148A Medicines composition for treating coronary heart disease ventricular premature beat and its prepn
03/19/2003CN1403144A Chinese medicine prepn with the functions of promoting blood circulation, dispersing blood clots, regulating vital energy and stopping pain
03/19/2003CN1403142A Suppository for treating piles and other anorectal diseases and its prepn
03/19/2003CN1403137A Heart-nourishing tea capsule and its prepn
03/19/2003CN1403126A Haidan medicine for treating cardiac and cerebral vascular diseases and its prepn
03/19/2003CN1403125A Chinese herbal medicine for treating coronary heart disease and angina pectoris and its prepn
03/19/2003CN1403121A Piles treating medicine and its prepn
03/19/2003CN1403119A Medicine for treating cerebral thrombus and its prepn
03/19/2003CN1403116A Heart disease treating medicine
03/19/2003CN1403106A Chinese medicine granule for treating cardiac and cerebral diseases and its prepn
03/19/2003CN1403098A Ointment for treating piles and other anorectal diseases and its prepn
03/19/2003CN1403089A Chinese medicine prepn containing arasaponin and its prepn process
03/19/2003CN1403088A Medicine composition containing polydatin or its salt and its use in preparing medicine
03/19/2003CN1403086A Coculine-phosphatide composite and its prepn
03/19/2003CN1403083A Fast disintegrated and stripped oral cilostazol table and its prepn process
03/19/2003CN1403082A Orally disintegrating Nifedipine prepn and its recipe
03/19/2003CN1403080A Application of kaempferol and its derivative in preparing medicine for cardiac and cerebral vascular diseases
03/19/2003CN1103338C Heterocyclic compound for treating myocardial ischaemia
03/18/2003WO2002024637A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
03/18/2003US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction
03/18/2003US6534676 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534534 Administering indazole-3-methyleneoxyalkanoic acid derivative to treat atherosclerosis
03/18/2003US6534521 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534515 20,21-dinor-eburnamenines
03/18/2003US6534510 Anticoagulants
03/18/2003US6534497 Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
03/18/2003US6534495 Anticoagulants that prevent thrombin-related diseases.
03/18/2003US6534478 Cyclic azapeptides with angiogenic effect
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534093 Immediate release eplerenone compositions
03/18/2003CA2422709A1 Substituted cinnamic acid guanidides, method for the production thereof,their use as a medicament, and to a medicament containing these compounds
03/18/2003CA2269994C 7-hetero-bicyclo¬2.2.1|-heptanes
03/18/2003CA2268028C 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/18/2003CA1341425C Antibodies to angiogenin: immunotherapeutic agents
1 ... 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 ... 1595